This federal contract award, valued at $2,124.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Oseltamivir Phosphate 30 mg capsules. It is a Firm Fixed Price contract with an ultimate completion date of January 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $1,328.80 and an ultimate completion date of January 7, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,317.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,562,181,703 units of Oseltamivir Phosphate 75 mg capsules, with an ultimate completion date of September 15, 2023. The contract is not designated with a set-aside requirement, indicating open competition. It is part of a larger Indefinite...
This contract award, valued at $1,870.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,640,790 units of the drug Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract does not have a set-aside designation, indicating open competition. It is a firm-fixed price delivery order with a performance period extending to December 9,...
The Defense Logistics Agency (DLA) awarded a $2,031.69 firm-fixed-price delivery order (SPE2DB22D1017|SPE2DB25FF5HM) to AmerisourceBergen Drug Corp for the supply of 4,567,248,922 units of the pharmaceutical drug Oseltamivir Phosphate 75 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation,...
The federal contract award is for the delivery of 4,563,327,071 units of the pharmaceutical product Oseltamivir Phosphate 75 mg Capsules. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,188.72 and an ultimate completion date of January 16, 2024. The contract is not designated with a set-aside and appears to be an...
This federal contract award is for the delivery of Oseltamivir Phosphate 75 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $1,703.80 and a performance period through March 19, 2024. It is not associated with any set-aside...
This federal contract award, valued at $2,820.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,563,311,234 units of Oseltamivir Phosphate 75 mg capsules. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,881.50 delivery order contract is for the provision of 4,567,267,230 units of the drug Oseltamivir Phosphate 75 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oseltamivir Phosphate 75 mg capsules, a generic antiviral medication used to treat influenza. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,121.23 and a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery...